Prior exposure to palatable solutions enhances the effects of naltrexone on food intake in rats

Pharmacology, Biochemistry, and Behavior
R B KanarekL S Monfared

Abstract

Previous research has suggested that chronic intake of palatable foods and fluids enhances the activity of the endogenous opioid system. To examine this suggestion, the effect of naltrexone on food intake was examined in male Long-Evans rats with or without prior exposure to palatable solutions. In Experiment 1, rats were fed laboratory chow alone or laboratory chow and a 32% sucrose solution, and in Experiment 2, were fed chow alone, chow and a 32% Polycose solution, or chow and a 0.15% saccharin solution for three weeks. The sucrose, Polycose, and saccharin solutions were removed 18 h prior to drug administration. Rats then received injections of naltrexone hydrochloride (0.0, 0.3 or 3.0 mg/kg. sc) and chow intakes were measured during the subsequent 1, 2, 4, 6 and 24 h. Naltrexone injections had minimal effects on intakes of animals which previously had consumed only chow. In contrast, naltrexone led to significant dose-related decreases in chow intakes in rats which had previously consumed the sucrose, Polycose, or saccharin solutions. These results provide confirmation for the suggestion that chronic intake of palatable solutions alters the activity of the endogenous opioid system.

References

Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·R B KanarekR Marks-Kaufman
Jan 1, 1990·Pharmacology, Biochemistry, and Behavior·D S Roane, R J Martin
Jan 1, 1990·Psychopharmacology·M R YeomansJ A Critchley
Feb 1, 1989·Journal of the American College of Nutrition·R Marks-KaufmanG F Barbato
Aug 1, 1989·Pharmacology, Biochemistry, and Behavior·B A Gosnell, M J Majchrzak
Apr 1, 1986·Pharmacology, Biochemistry, and Behavior·W C Lynch
Jan 1, 1987·Neuroscience and Biobehavioral Reviews·A Sclafani
Mar 1, 1983·Pharmacology, Biochemistry, and Behavior·J DumA Herz
May 1, 1984·Pharmacology, Biochemistry, and Behavior·M C BertiereM Apfelbaum
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·R Marks-KaufmanE Gross
Aug 1, 1984·Pharmacology, Biochemistry, and Behavior·J Dum, A Herz
Feb 1, 1984·Physiology & Behavior·A Sclafani, S Xenakis
Dec 1, 1982·Physiology & Behavior·G A Rockwood, L D Reid
Jul 1, 1981·Pharmacology, Biochemistry, and Behavior·M Apfelbaum, A Mandenoff
May 1, 1993·Pharmacology, Biochemistry, and Behavior·C A FryeR B Kanarek
Aug 1, 1996·Pharmacology, Biochemistry, and Behavior·K E d'AnciR Marks-Kaufman
Mar 1, 1997·Pharmacology, Biochemistry, and Behavior·K E D'AnciR Marks-Kaufman
Sep 1, 1997·Pharmacology, Biochemistry, and Behavior·R B KanarekR Marks-Kaufman

❮ Previous
Next ❯

Citations

Jul 6, 2000·Pharmacology, Biochemistry, and Behavior·K E D'AnciR B Kanarek
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·R B Kanarek, B Homoleski
Mar 27, 2001·Pharmacology, Biochemistry, and Behavior·S Mandillo, R B Kanarek
Aug 26, 1998·Pharmacology, Biochemistry, and Behavior·R B KanarekK E D'Anci
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·R B KanarekW F Mathes
Apr 20, 1999·Pharmacology, Biochemistry, and Behavior·S Shabir, T C Kirkham
May 26, 1999·Pharmacology, Biochemistry, and Behavior·K E D'Anci
Jan 8, 1999·Peptides·G A OlsonA J Kastin
Nov 23, 2005·Behavioral Neuroscience·Mary M BoggianoPamela K Wauford
Sep 25, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Valentina De ChiaraDiego Centonze
Aug 2, 2007·PloS One·Magalie LenoirSerge H Ahmed
May 4, 2011·Physiology & Behavior·Pawel K OlszewskiAllen S Levine
Jul 8, 2008·Physiology & Behavior·Kristine B BonacchiAnthony Sclafani
Nov 15, 2008·Obesity·Ling XuXiao-feng Wang
Jul 6, 2004·Physiology & Behavior·Andras Hajnal, Ralph Norgren
Jun 22, 2005·Brain Research·David C JewettAllen S Levine
Sep 15, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·P J RogersD J Mela
Apr 17, 2004·Nutritional Neuroscience·Kristen E D'Anci, Robin B Kanarek
Apr 24, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sonja K BillesMichael A Cowley
Aug 25, 2017·British Journal of Sports Medicine·James J DiNicolantonioWilliam L Wilson
Mar 11, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·J D PomonisA S Levine
Apr 13, 2021·Pharmacology, Biochemistry, and Behavior·Meenu MinhasFrancesco Leri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved